Inkef Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
88
- Portfolio
-
29
- Exits
-
24
Inkef General Information
Company Description
Founded in 2010, Inkef Capital is a venture capital firm based in Amsterdam, Netherlands. The firm prefers to invest in companies operating in the healthcare and technology sectors.
Business Details
Website
www.inkef.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- ITO toren
- Gustav Mahlerplein 104
- 1082 MA Amsterdam
- Netherlands
Inkef Investments (88)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Draupnir Bio | 17-Jul-2024 | Seed Round | 000.00 | Drug Discovery | Pre-Clinical Trials | 0000 000000 |
iOnctura | 20-Jun-2024 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - General | 00000 00000 |
Provable Labs | 08-May-2024 | 00000 00000 | 000 | Financial Software | Generating Revenue | |
Silverflow | 16-Apr-2024 | 00000 00000 | 000.00 | Financial Software | Generating Revenue | |
ONWARD Medical | 25-Mar-2024 | 0000 | 000.00 | Therapeutic Devices | Generating Revenue | |
Corporis | 20-Dec-2023 | 00000 00000 | 00.00 | Surgical Devices | Clinical Trials - General | |
NMD Pharma | 15-Nov-2023 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 2 | 000000 00000 |
VarmX | 25-May-2023 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | 0000 0000000 |
Anavo Therapeutics | 02-May-2023 | Seed Round | 000.00 | Drug Discovery | Generating Revenue | 000000 00000 |
QurAlis | 09-Mar-2023 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000 0000000 |
Inkef Exits (24)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Cardior | 25-Mar-2024 | Merger/Acquisition | 00.000 |
Lengoo | 19-Mar-2024 | 0000000000: | |
Calypso Biotech | 07-Jan-2024 | 000000000000 | 00000 |
InteRNA Technologies | 27-Mar-2023 | 0000000000: | |
Cashforce | 15-Jun-2022 | 000000000000 | 000.00 |
Sentinels (Den Haag) | 25-Apr-2022 | 0000000000 | |
GeoPhy | 28-Feb-2022 | 000000000000 | 00000 |
Aidence | 20-Jan-2022 | 000000000000 | 000.00 |
ONWARD Medical | 21-Oct-2021 | IPO | 000.00 |
GitLab | 14-Oct-2021 | IPO | 00000 |
Inkef Investments by Industry, Year, and Region
Inkef Management, Team & Partners (51)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Reitze Douma | Managing Partner | Amsterdam, Netherlands | |||
Frank Lansink | Senior Partner | 0 | Amsterdam, Netherlands | ||
Simone Botti Ph.D | Senior Partner | 0 | 0 | 0 | Amsterdam, Netherlands |
Ivan Burkov Ph.D | Junior Partner | 0 | 0 | Amsterdam, Netherlands | |
Thijs Cohen Tervaert MD | Partner | 0 | 0 | Amsterdam, Netherlands |
Inkef Co-Investors (156)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
LSP Management Group | 5 | 0 | 0 | ||
BioGeneration Ventures | 0 | 0 | |||
BioMedPartners | 0 | 0 | 0 | ||
Invest-NL (Investment Company) | 0 | 0 | 0 | ||
Novo Holdings | 0 | 0 |
Inkef FAQs
-
What is Inkef?
Founded in 2010, Inkef Capital is a venture capital firm based in Amsterdam, Netherlands.
-
When was Inkef founded?
Inkef was founded in 2010.
-
Who is the founder of Inkef?
Frank Landsberger Ph.D is the founder of Inkef.
-
Where is Inkef headquartered?
Inkef is headquartered in Amsterdam, Netherlands.
-
What is Inkef's total asset value?
Inkef has around 00000 in total assets under management.
-
How many investments has Inkef made?
Inkef has made 88 investments.
-
What has Inkef invested in?
Inkef has made numerous investments in companies like Draupnir Bio, iOnctura, and Provable Labs within the Drug Discovery and Financial Software industries.
-
What has Inkef invested in recently?
Inkef's latest investment was on 17-Jul-2024 in Draupnir Bio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »